Qilian International - QLI Expected Profit

Public company logo of Qilian International (QLI)

Qilian International (QLI) serves as a leading developer in the field of raw material purification and bioactive extraction. This chart of expected financial results confirms this status, where the value of captures current market expectations. The business relies on domestic consumption cycles, which establishes it as a defensive asset. However, geopolitical tensions and sanctions could complicate component logistics and international certification.

QLI - Qilian International Corp Future Net Profit over the range 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Qilian International Corp (QLI)

Fundamental company valuation:QLI, qlsyy.net
Finished products of Qilian International Holding Group Limited

The implementation of ESG standards and purification systems in Qilian International (QLI) pharmaceutical production directly impacts the expected profit growth. This indicator determines the future net income of the business after deducting all operating expenses and taxes. The metric is calculated as a projected profit sum, reflecting the capital density of the asset. Positive dynamics confirm the issuer's financial stability, characterizing the securities as a moderate-risk instrument.

Competitors of Qilian International (QLI)

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Expected Net Income|Projected Future Earnings SPRY (ARS Pharmaceuticals Inc)|Future Net Profit TBPH (Theravance)|AQST - Expected Profit|scPharmaceuticals (SCPH) - Future Profit|TECX: Projected Future Earnings|Net Profit Forecast TNXP|Expected Profit China SXT Pharmaceuticals, Inc.|EPRX: Expected Net Income|Projected Future Earnings BHST|EXOZ - Expected Net Profit|Projected Future Earnings ORMP (oramed.com)|Projected Future Earnings enterabio.com ENTX|HYFT - Expected Profit|Company Profit Forecast ABVC BioPharma, Inc ABVC|CPIX: Projected Future Earnings|Quantum BioPharma Ltd - Expected Net Income|Future Profit FGEN|Telomir Pharmaceuticals, Inc. - Forward Earnings|Projected Future Earnings RANI|SNYR (Synergy CHC) - Expected Net Income|Expected Profit Rallybio RLYB|Lexaria Bioscience (LEXX) - Expected Net Profit|PULM - Expected Profit|Company Profit Forecast Pheton Holdings PTHL|APM (Aptorum) - Future Profit|Lyra Therapeutics, Inc. (LYRA) - Projected Future Earnings|IBO (impactbiomedinc.com) - Projected Future Earnings|TNFA (TNF Pharmaceuticals) - Future Net Profit|Expected Profit cbdmd.com (YCBD)|Company Profit Forecast PainReform Ltd|Projected Future Earnings CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Expected Net Profit|OPTN - Expected Profit|Pieris Pharmaceuticals - Future Net Profit|PROC (Procaps Group) - Future Profit|PTPI - Company Profit Forecast|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast